N. Panzera

Interleukin-32 in systemic sclerosis, a potential new biomarker for pulmonary arterial hypertension

C. Vizza, G. Guggino, F. Ciccia, 2020, Arthritis Research & Therapy.

Tofacitinib May Inhibit Myofibroblast Differentiation from Rheumatoid-Fibroblast-like Synoviocytes Induced by TGF-β and IL-6

A. Angelucci, F. Ciccia, R. Giacomelli, 2022, Pharmaceuticals.

The role of extracellular matrix components in angiogenesis and fibrosis: Possible implication for Systemic Sclerosis

R. Giacomelli, P. Ruscitti, P. Di Benedetto, 2018, Modern rheumatology.

Blocking CD248 molecules in perivascular stromal cells of patients with systemic sclerosis strongly inhibits their differentiation toward myofibroblasts and proliferation: a new potential target for antifibrotic therapy

G. Guggino, F. Ciccia, R. Giacomelli, 2018, Arthritis Research & Therapy.

Mesenchymal stem cells of Systemic Sclerosis patients, derived from different sources, show a profibrotic microRNA profiling

A. Di Marco, A. Tessitore, G. Guggino, 2019, Scientific Reports.